Sonnet BioTherapeutics Holdings, Inc.

SONNNASDAQ Capital Market·USD·Closed

SONNNASDAQ·USD·Closed

$1.26

−59.35%

$1.26

−$1.84 (59.35%)

52W Range

1thpctl

Volume

9.23×avg

Mkt Cap

8.43MUSD

P/E

-0.3TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

1thpctl

Volume

9.23×avg

Market Cap

8.43MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+5268.8% / yr

Operating margin-1584.4%

ROIC-144.2%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio3.50×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required